Compound: Selumetinib

Drug Target: MEK1, MEK2

Drug Target pathway: ERK MAPK signaling

Dataset


Tissue specific analysis

Statistics

All cell lines
Number of cell lines
Pearson correlation
Spearman correlation

Chart settings

Colour dots by:


Display features:

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.